PPMX (Drug Discovery) Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Public

  • Employees
  • 37

Employees

  • Stock Symbol
  • 4882

Stock Symbol

  • Share Price
  • $0.79
  • (As of Friday Closing)

PPMX (Drug Discovery) General Information

Description

Perseus Proteomics Inc is engaged in the research and development, manufacture, and sales of pharmaceuticals. It provides antibody-based therapeutics and diagnostic drugs to cure cancer and other diseases. The Company operates in a single segment, the pharmaceutical business.

Contact Information

Website
www.ppmx.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 4-7-6, Komaba, Meguro-ku
  • Tokyo Park Building
  • Tokyo, 153-0041
  • Japan
+81
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
TKS
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 4-7-6, Komaba, Meguro-ku
  • Tokyo Park Building
  • Tokyo, 153-0041
  • Japan
+81

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PPMX (Drug Discovery) Stock Performance

As of 13-Nov-2026, PPMX (Drug Discovery)’s stock price is $0.79. Its current market cap is $14.5M with 18.4M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.79 $0.78 $0.73 - $2.15 $14.5M 18.4M 470K -$0.31

PPMX (Drug Discovery) Financials Summary

As of 30-Jun-2026, PPMX (Drug Discovery) has a trailing 12-month revenue of $953K.

In Thousands,
USD 		TTM 30-Jun-2026 FY 2026 31-Mar-2026 FY 2025 31-Mar-2025 FY 2024 31-Mar-2024
EV 7,334 12,569 58,556 15,259
Revenue 953 899 789 695
EBITDA (4,783) (5,911) (7,607)
Net Income (4,822) (4,764) (5,933) (7,644)
Total Assets 10,283 10,156 12,155 11,191
Total Debt 0 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

PPMX (Drug Discovery) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore PPMX (Drug Discovery)‘s full profile, request access.

Request a free trial

PPMX (Drug Discovery) Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion
Price		 % Owned

This information is available in the PitchBook Platform. To explore PPMX (Drug Discovery)‘s full profile, request access.

Request a free trial

PPMX (Drug Discovery) Patents

  • 360

    Total Documents Applications and Grants

  • Total Patents Families

  • 150

    Granted

  • 67

    Pending

  • Expiring in next 12 mo

PPMX (Drug Discovery) Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026116414-A1 Method for extracting target sequence from library Pending 28-Nov-2024
WO-2026116332-A1 Therapeutic agent for cardiovascular diseases Pending 27-Nov-2024
JP-2025160972-A Dosage and administration of therapeutic agent comprising substance that recognizes transferrin receptor Pending 11-Apr-2024
JP-2025160659-A Efficacy prediction marker for substance recognizing transferrin receptor Pending 10-Apr-2024
WO-2025216210-A1 Specification of nucleic acid molecule using identification molecule Pending 08-Apr-2024
To view PPMX (Drug Discovery)’s complete patent history, request access »

PPMX (Drug Discovery) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PPMX (Drug Discovery) Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore PPMX (Drug Discovery)‘s full profile, request access.

Request a free trial

PPMX (Drug Discovery) ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view PPMX (Drug Discovery)’s complete esg history, request access »

PPMX (Drug Discovery) FAQs

  • When was PPMX (Drug Discovery) founded?

    PPMX (Drug Discovery) was founded in 2001.

  • Where is PPMX (Drug Discovery) headquartered?

    PPMX (Drug Discovery) is headquartered in Tokyo, Japan.

  • What is the size of PPMX (Drug Discovery)?

    PPMX (Drug Discovery) has 37 total employees.

  • What industry is PPMX (Drug Discovery) in?

    PPMX (Drug Discovery)’s primary industry is Drug Discovery.

  • Is PPMX (Drug Discovery) a private or public company?

    PPMX (Drug Discovery) is a Public company.

  • What is PPMX (Drug Discovery)’s stock symbol?

    The ticker symbol for PPMX (Drug Discovery) is 4882.

  • What is the current stock price of PPMX (Drug Discovery)?

    As of 13-Nov-2026 the stock price of PPMX (Drug Discovery) is $0.79.

  • What is the current market cap of PPMX (Drug Discovery)?

    The current market capitalization of PPMX (Drug Discovery) is $14.5M.

  • What is PPMX (Drug Discovery)’s current revenue?

    The trailing twelve month revenue for PPMX (Drug Discovery) is $953K.

  • What is PPMX (Drug Discovery)’s annual earnings per share (EPS)?

    PPMX (Drug Discovery)’s EPS for 12 months was -$0.31.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process